Rare Neurological Disease Treatment Market Trends 2034: Advancements in Gene Therapy, RNA-Based Treatments, and Biologics
According to The Insight Partners, the Rare Neurological Disease Treatment Market was valued at US$ 7.6 billion in 2021 and is expected to reach US$ 14.5 billion by 2031, registering a CAGR of 8.7% from 2023–2031. The total addressable market during 2023–2031 is projected at approximately US$ 123.73 billion. Clinical trials and drug research to treat rare neurological diseases are...
0 Comments 0 Shares 140 Views 0 Reviews